PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsTinea pedis
MeSH D014008 - tinea pedis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D014005:Tinea
$
Success rate
D011537:Pruritus
D005533:Foot dermatoses
D014008: 
Tinea pedis
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCiclopirox Ciclopirox  2007-09-18   
Clotrimazole Clotrimazole  1995-02-28   
Clotrimazole Gynix  1998-02-13   
Ketoconazole Ketoconazole  1999-06-15   
Miconazole Miconazole  1992-10-30   
PadagisCiclopirox Ciclopirox  2006-03-03   
Clotrimazole Clotrimazole  2005-10-28   
Econazole Econazole  2004-06-23   
Ketoconazole Ketoconazole  2004-01-07   
Taro PharmaceuticalButenafine Butenafine  2017-11-16   
Ciclopirox Ciclopirox  2005-04-12   
Clotrimazole Clotrimazole  1993-08-31   
Clotrimazole, Betamethasone Clotrimazole Betamethasone  2001-05-29   
Econazole Econazole  2002-11-26   
Ketoconazole Ketoconazole  1999-06-15   
Ketoconazole Ketozole  2002-12-18   
Miconazole Miconazole  1997-01-13   
Naftifine Naftifine  2016-09-08   
OXICONAZOLE Oxiconazole  2016-03-07   
Terbinafine Terbinafine  2007-07-02   
Clotrimazole Trivagizole  2000-04-12   
Glenmark PharmaceuticalsCiclopirox Ciclopirox  2009-11-10   
Clotrimazole Clotrimazole  2010-08-03   
Clotrimazole, Betamethasone Clotrimazole Betamethasone  2015-10-30   
Terbinafine Terbinafine  2007-07-02   
Resilia PharmaceuticalsEconazole Ecoza 2031-08-08 2013-10-24   
MylanCiclopirox Ciclopirox  2007-09-18   
Ketoconazole Extina  2007-06-12   
Butenafine Mentax  1996-10-18   
Butenafine Mentax-tc  2002-10-17   
Terbinafine Terbinafine  2007-07-02   
Miconazole, White petrolatum Vusion 2028-03-30 2006-02-16   
XiromedKetoconazole Ketoconazole  2021-05-21   
Naftifine Naftifine  2020-09-22   
Johnson & JohnsonMiconazole Monistat  1982-01-01   
Ketoconazole Nizoral  1986-11-07   
PerrigoMiconazole Miconazole  1997-03-20   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
86%
6/7
Phase 2
50%
6/12
Phase 3
89%
24/27
Approved: 15Overall Success rate: 38%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Padagis
Taro Pharmaceutical
1
2
3
4
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use